Cited by 97Cardiac Ischemia and ReperfusionHyperglycemia and glycemic control in critically ill and hospitalized patientsAcute Myocardial Infarction Research

Insulin: An endogenous cardioprotector

Das, Undurti N.·2003·Current Opinion in Critical Care

Abstract

This review discusses the myocardial protective property of the insulin/glucose-insulin-potassium regimen and the mechanisms involved in this beneficial action. Several recent studies suggest that insulin not only is useful to control hyperglycemia and maintain glucose homeostasis but also may have the unique property to protect the myocardium from reperfusion injury and ischemia and prevent apoptosis of myocardial cells. The insulin/glucose-insulin-potassium (GIK) regimen suppresses the production of tumor necrosis factor-alpha, interleukin-6, macrophage migration inhibitory factor and other pro-inflammatory cytokines, and free radicals; and enhances the synthesis of endothelial nitric oxide and anti-inflammatory cytokines interleukin-4 and interleukin-10. Thus, the insulin/GIK regimen brings about its cardioprotective action. This may also explain why the insulin/GIK regimen is useful in sepsis and septic shock, myocardial recovery in acute myocardial infarction, and critical illness. It is suggested that the infusion of adequate amounts of insulin to patients with acute myocardial infarction, congestive heart failure, cardiogenic shock, and critical illness preserves myocardial integrity and function and ensures rapid recovery. In view of the suppressive action of insulin on the synthesis of proinflammatory cytokines and free radicals, it is possible that the insulin/GIK regimen, when used in a timely and appropriate fashion, may also protect other tissues and organs and facilitate in the recovery of patients who are critically ill.

Integrity signals

Registry

Crossref · 10.1097/00075198-200310000-00007

Cites

67 of 67 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The insulin receptor shares a signaling pathway with eNOS activation to regulate postprandial blood flow and efficient nutrient disposition to peripheral tissues.

    “The insulin receptor shares a signaling pathway with the activation of endothelial NOS (eNOS) [19,48,49,50,51,52] to regulate the postprandial blood flow and efficient nutrient disposition to peripheral tissues”

    From NO-Rich Diet for Lifestyle-Related Diseases (2015) · cites this paper as [48]

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Das, U. N.
Corresponding author
Das, Undurti N.
Venue
Current Opinion in Critical Care
Published
2003-10
Volume
9
Issue
5
Pages
375-383
ISSN
1070-5295 (ISSN-L)
OpenAlex
W3023288245
Cited by
97
References
67
Citations by year
2024: 1 · 2023: 1 · 2022: 3 · 2021: 1 · 2018: 2 · 2017: 3 · 2016: 5 · 2015: 4 · 2014: 2 · 2013: 5 · 2012: 5
FWCI
1.52
Type
journal article
Language
en
Open access
closed
Locations
  • Current Opinion in Critical Care (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Pathology and Forensic Medicine › Cardiac Ischemia and Reperfusion
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
  • Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Acute Myocardial Infarction Research
Keywords
insulin, cardioprotection, myocardial ischemia, ischemia-reperfusion injury, apoptosis, inflammatory cytokines, TNF-α, interleukin-6, IL-10, IL-4, macrophage migration inhibitory factor, free radicals, nitric oxide, sepsis, septic shock, acute myocardial infarction, congestive heart failure, cardiogenic shock, critical illness, hyperglycemia
MeSH terms
Animals, Blood Glucose, Glucose, Humans, Hyperglycemia, Insulin, Insulin Resistance, Macrophage Migration-Inhibitory Factors, Myocardial Infarction, Nitric Oxide, Potassium, Shock, Septic, Tumor Necrosis Factor-alpha, Diabetic Ketoacidosis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review